CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 61 filers reported holding CITIUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67,048 | -21.4% | 98,024 | +37.8% | 0.00% | – |
| Q2 2023 | $85,354 | +19842.5% | 71,128 | +19333.9% | 0.00% | – |
| Q1 2023 | $428 | -57.2% | 366 | -67.7% | 0.00% | – |
| Q2 2022 | $1,000 | -97.7% | 1,132 | -95.3% | 0.00% | – |
| Q1 2022 | $43,000 | -71.3% | 24,231 | -75.2% | 0.00% | – |
| Q4 2021 | $150,000 | +30.4% | 97,692 | +72.1% | 0.00% | – |
| Q3 2021 | $115,000 | -29.9% | 56,762 | +20.5% | 0.00% | – |
| Q2 2021 | $164,000 | -18.4% | 47,093 | -58.3% | 0.00% | – |
| Q1 2021 | $201,000 | +93.3% | 112,993 | +10.6% | 0.00% | – |
| Q4 2020 | $104,000 | +1055.6% | 102,182 | +1214.4% | 0.00% | – |
| Q2 2020 | $9,000 | +125.0% | 7,774 | +113.2% | 0.00% | – |
| Q2 2019 | $4,000 | +300.0% | 3,647 | +448.4% | 0.00% | – |
| Q4 2018 | $1,000 | -83.3% | 665 | -74.1% | 0.00% | – |
| Q2 2018 | $6,000 | -64.7% | 2,572 | -53.6% | 0.00% | – |
| Q1 2018 | $17,000 | +183.3% | 5,545 | +268.4% | 0.00% | – |
| Q4 2017 | $6,000 | 0.0% | 1,505 | -20.3% | 0.00% | – |
| Q3 2017 | $6,000 | – | 1,889 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 188,796 | $291,000 | 0.08% |
| Horst & Graben Wealth Management LLC | 75,722 | $117,000 | 0.03% |
| Alpine Global Management, LLC | 83,475 | $129,000 | 0.02% |
| Miller Investment Management, LP | 50,000 | $77,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 30,863 | $48,000 | 0.01% |
| WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC | 49,075 | $76,000 | 0.00% |
| Alberta Investment Management Corp | 172,185 | $265,000 | 0.00% |
| Syverson Strege & Co | 2,145 | $3,000 | 0.00% |
| HighTower Advisors, LLC | 170,623 | $263,000 | 0.00% |
| HRT FINANCIAL LP | 90,871 | $139,000 | 0.00% |